VCP Scanner
ScreenerTechnicalBreakoutsThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistPricing
ScreenerTechnical ScannerBreakoutsThemes
Earnings
WatchlistPricing
Ctrl K
ALAB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
ALABAstera Labs, Inc. Common Stock
$320.17$54.9B
Overview & Verdict
OverviewVisualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksALABBalance Sheet

Astera Labs, Inc. Common Stock (ALAB) Balance Sheet

4Y historyFree accessUpdated daily

The balance sheet is debt-free with a current ratio of 10.05 and equity of $1.7B, though cash has declined to $111.5M from $421.1M in Q2 2024, and goodwill of $91.6M warrants monitoring.

ALAB Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22
Total Current Assets1.65B1.36B1.01B185.81M206M
Cash & Short-Term Investments1.25B1.19B914.3M149.31M163.14M
Cash Only111.45M167.61M79.55M45.1M76.09M
Short-Term Investments1.14B1.02B834.75M104.22M87.06M
Accounts Receivable192.47M83.2M38.81M8.34M10.72M
Days Sales Outstanding34.4235.6235.7526.2748.99
Inventory113.78M58.98M43.22M24.09M28.87M
Days Inventory Outstanding86.87103.86168.54244.52497.33
Other Current Assets92.69M31.03M16.65M686K509K
Total Non-Current Assets279.61M169.79M41.53M10.48M5.73M
Property, Plant & Equipment119.28M92.04M35.65M7.58M3.52M
Fixed Asset Turnover12.62x9.26x11.12x15.27x22.67x
Goodwill91.56M0000
Intangible Assets00000
Long-Term Investments00000
Other Non-Current Assets68.77M77.75M5.88M2.9M2.2M
Total Assets1.93B1.53B1.05B196.29M211.73M
Asset Turnover0.74x0.56x0.38x0.59x0.38x
Asset Growth %187.64%45.26%437.21%-7.29%-
Total Current Liabilities164.31M133.04M86.54M35.08M40.09M
Accounts Payable53.93M42.36M26.92M6.34M10.29M
Days Payables Outstanding54.3174.6104.9864.31177.32
Short-Term Debt00000
Deferred Revenue (Current)0015M00
Other Current Liabilities85.8M90.68M37.92M11.66M9.71M
Current Ratio10.05x10.24x11.71x5.30x5.14x
Quick Ratio9.36x9.79x11.21x4.61x4.42x
Cash Conversion Cycle66.9864.8999.3206.48369
Total Non-Current Liabilities41.49M35.15M3.17M3.79M256.93M
Long-Term Debt00000
Capital Lease Obligations98.18M35.15M0778K0
Deferred Tax Liabilities00000
Other Non-Current Liabilities41.49M03.17M3.01M256.93M
Total Liabilities205.8M168.19M89.71M38.87M297.02M
Total Debt035.15M1.29M2.93M1.6M
Net Debt-111.45M-132.46M-78.27M-42.16M-74.49M
Debt / Equity0.00x0.03x0.00x0.02x-
Debt / EBITDA0.00x0.19x---
Net Debt / EBITDA-0.39x-0.73x---
Interest Coverage-----
Total Equity1.73B1.36B964.8M157.43M-85.29M
Equity Growth %179.67%41.34%512.86%284.57%-
Book Value per Share9.477.597.351.03-0.65
Total Shareholders' Equity1.73B1.36B964.8M157.43M-85.29M
Common Stock17K17K16K4K4K
Retained Earnings243.74M10.34M-208.8M-125.38M-99.12M
Treasury Stock00000
Accumulated OCI-3.37M4.31M426K259K-229K
Minority Interest00000

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrong
Balance SheetHealthy
Cash FlowRobust
Top Statement Risk

Extreme valuation and insider selling

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Balance Sheet Strengthens with Profitability

Astera Labs' equity surged to $1.7B in Q2 2026 from $808.8M in Q1 2024, as reported in SEC filings, driven by a $243.7M retained earnings swing, signaling a rapid transition from loss-making to highly profitable operations.

The balance sheet has transformed from a net deficit position to a fortress-like equity base, with total assets nearly doubling to $1.9B over ten quarters. The inflection in Q1 2025, when retained earnings turned positive, aligns with the AI-driven revenue surge, suggesting that profitability is now self-funding growth. This trajectory indicates a structural improvement in financial health, though the pace of asset growth may moderate as the company matures.

Minimal Leverage Masks Strategic Flexibility

Astera Labs carries negligible debt, with D/E at 0.03 in Q1 2026 and zero debt in Q2 2026, as per balance sheet data, providing ample financial flexibility to fund R&D and potential M&A without interest burden.

The company's debt levels have been consistently minimal, with total debt never exceeding $58.2M, and the most recent quarter shows complete debt elimination. This conservative leverage, combined with a current ratio above 10, suggests that the company is not reliant on external financing, which is typical for a high-growth fabless semiconductor firm. The absence of debt reduces refinancing risk and positions the balance sheet to withstand potential downturns, though investors should note that the company may be under-leveraged, potentially leaving value on the table.

Asset Mix Reflects Fabless Model

Astera Labs' asset base is dominated by current assets, with PPE net of $119.3M in Q2 2026, as reported in financial statements, representing only 6.3% of total assets, underscoring a capital-light, fabless business model.

The low PPE intensity is consistent with a fabless semiconductor company that outsources manufacturing, allowing it to scale without heavy fixed investment. Goodwill of $91.6M, which appeared in Q1 2026, likely stems from an acquisition, and while it is not yet impaired, investors should monitor for potential write-downs if the acquired technology underperforms. The asset mix suggests that the company's value lies in its intellectual property and working capital management rather than physical assets, which is typical for high-margin, design-centric firms.

Retained Earnings Swing Signals Profitability

Astera Labs' retained earnings swung from -$218.4M in Q1 2024 to $243.7M in Q2 2026, as per balance sheet data, a $462.1M turnaround that underscores the company's rapid transition to sustained profitability.

The dramatic improvement in retained earnings is a direct result of the AI-driven revenue surge, with net income turning positive in Q1 2025 and accelerating since. This equity build-up is primarily organic, reflecting strong earnings retention rather than external capital raises, which is a positive signal for shareholders. However, the company's stock-based compensation, which totaled $64M in Q2 2026, may dilute existing shareholders over time, and investors should adjust for this when assessing equity quality.

Ample Liquidity Buffer Despite Cash Dip

Astera Labs' current ratio stands at 10.05 in Q2 2026, as reported in financial statements, with cash of $111.5M, down from $421.1M in Q2 2024, indicating a strong liquidity position that can absorb operational shocks.

The current ratio has remained above 10 for the past ten quarters, reflecting a highly liquid balance sheet with minimal short-term obligations. The decline in cash from $696.1M in Q1 2024 to $111.5M in Q2 2026 is likely due to investments in working capital and acquisitions, but the company still holds sufficient cash to cover near-term liabilities. This liquidity provides a buffer against potential demand volatility, though the cash burn in Q2 2026, driven by a $143.5M working capital outflow, warrants monitoring to ensure it does not persist.

Goodwill and SBC Distort Balance Sheet

Astera Labs' balance sheet may be distorted by $91.6M in goodwill and significant stock-based compensation, as per recent filings, which could overstate asset quality and understate dilution, warranting careful adjustment by investors.

The sudden appearance of goodwill in Q1 2026 suggests an acquisition, and while it is not impaired, the risk of future write-downs exists if the acquired business fails to meet growth expectations. Additionally, the company's heavy use of stock-based compensation, which totaled $64M in Q2 2026, inflates equity but dilutes existing shareholders, making reported equity appear stronger than the true economic value. Investors should adjust for these items to assess the balance sheet's real strength, as headline numbers may be misleading.

ALAB — Frequently Asked Questions

Quick answers to the most common questions about buying ALAB stock.

What are the total assets of Astera Labs, Inc. Common Stock (ALAB)?

As of 2025, Astera Labs, Inc. Common Stock (ALAB) had total assets of $1.53B including $1.36B in current assets.

How much debt does Astera Labs, Inc. Common Stock (ALAB) have?

Astera Labs, Inc. Common Stock (ALAB) carries total debt of $35.1M, offset by $1.19B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Astera Labs, Inc. Common Stock?

Astera Labs, Inc. Common Stock (ALAB) has total shareholders' equity (book value) of $1.36B ($7.59 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Astera Labs, Inc. Common Stock's current ratio and liquidity?

Astera Labs, Inc. Common Stock (ALAB) reported a current ratio of 10.24x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.